FDA inspection
Indus Medicare Limited: FDA inspection ending Jan 23, 2020
FDA inspection 1115963 · Official Action Indicated (OAI) · Medak District
Key facts
| Inspection ID | 1115963 |
|---|---|
| Firm | Indus Medicare Limited |
| FEI number | 3003759643 |
| Address | N H - 44 Ramaipally Village, Sy No 129 |
| City | Medak District |
| Country | India |
| Fiscal year | 2020 |
| Inspection end date | Jan 23, 2020 |
| Classification | Official Action Indicated (OAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
| Warning letter | 606159 |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data